skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Keep up with events as they unfolded at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021.

Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry. 

Spot new opportunities with an insider’s look at key findings, market trends, challenges, and innovations, as reported by the industry analysts at Pharma Intelligence.

Download Your J.P. Morgan 2021 Preview

 In preparation for the 39th Annual J.P. Morgan Annual Healthcare Conference, we have given you access to a detailed preview covering all the companies to watch for this year.
previewjpmorgan

J.P. Morgan Day 1: Report

Download the highlights & developments from day 1 now to get the insider knowledge on:

  • Amgen CEO On Deals: ‘We Have Deep Pockets, Short Arms’
  • Vertex Is Ready To Spend On Business Development
  • BioMarin Ready To Talk To FDA About Gene Therapy CRL
  • Alnylam Aims For Biotech Big Leagues With Five-Year Strategy
  • Veklury Not Gilead’s Only Highlight, O’Day Says
  • BioNTech And Pfizer Raise 2021 Goal To 2 Billion Vaccine Doses
  • New Merck KGaA CEO Ready To Take Up The COVID Challenge
day1jpmorgan

J.P. Morgan Day 2: Report

Download the highlights from day 2 now to get the headlines shaping the Pharma industry, including:

  • Pfizer CEO Bourla On Drug Pricing Reform
  • What’s Next At Merck & Co., And Its Newco
  • Novartis Changes PD-1 Strategy
  • Sanofi Actively Exploring Gene Therapy BD
  • AbbVie Plans To Grow Without Additional Deals
  • Biogen Partners With Apple In Digital Cognition Study

 

day2jpmorgan

J.P. Morgan Day 3: Report

Download the highlights from day 3 now to get the headlines shaping the Pharma industry, including: 

  • Teva CEO: Single-Digit Growth Is ‘Reasonable’
  • Relay Prepares SHP2 Drug To Sail With Roche's KRAS G12C Inhibitor
  • UCB Embraces The Digital Age
  • Ionis Confident In Competitive Prospects Of IONIS-TTR-LRx In ATTR
  • Agios Sees Mitapivat Potential Despite Gene Therapy Promise
jpmorganday4

J.P. Morgan Day 4: Report

Download the highlights from the final day now to get the headlines shaping the Pharma industry, including:

  • A Tailwind From COVID-19
  • Bolt-Ons Remain The Name Of The BD Game
  • BeiGene (BGNE) gives a tour of the company’s explosive growth
  • Ipsen announces a shift to their strategy
  • And more
JPmorgan Day 4
 

おすすめのニュース&レポート

;

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。

Eメール:inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。